Cancer Family
Gastric Neoplasm
CI-CAN-00000185Explore in graph →
Non-malignant720 active trials4 approved drugs55 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000185Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02423278 | The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer | unknown | Phase 2 / Phase 3 | 200 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Apr 22, 2015 | clinicaltrials |
| NCT01980407 | Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) in Patients With Advanced Gastric Cancer | unknown | Phase 2 | 49 | Jilin Provincial Tumor HospitalOTHER | 1 | Mar 5, 2015 | clinicaltrials |
| NCT01674959 | Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Feb 5, 2015 | clinicaltrials |
| NCT02311595 | A Phase II Clinical Trial of Reduced Port Totally Laparoscopic Distal Gastrectomy With D2 Lymph Node Dissection | unknown | Phase 2 | 67 | Samsung Medical CenterOTHER | 0 | Dec 8, 2014 | clinicaltrials |
| NCT02296658 | A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 20, 2014 | clinicaltrials |
| NCT02291211 | S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis | unknown | Phase 2 | 60 | Tang-Du HospitalOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT02250209 | T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy | unknown | Phase 2 | 40 | Chinese PLA General HospitalOTHER | 1 | Sep 26, 2014 | clinicaltrials |
| NCT02226380 | FOLFOX6 as Neoadjuvant Chemotherapy in Local Advanced Gastric Cancer(FOLFOX6) | unknown | Phase 2 | 75 | Peking Union Medical College HospitalOTHER | 1 | Aug 27, 2014 | clinicaltrials |
| NCT00004236 | Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | unknown | Phase 2 | — | University of LeicesterOTHER | 1 | Jun 24, 2014 | clinicaltrials |
| NCT02163291 | Study on Neoadjuvant Chemotherapy for Advanced Gastric Cancer | unknown | Phase 2 | 30 | Peking UniversityOTHER | 1 | Jun 13, 2014 | clinicaltrials |
| NCT02085031 | Intracorporeal Versus Extracorporeal Roux-en-Y Esophagojejunostomy During Laparoscopic Total Gastrectomy for Gastric Cancer | unknown | Phase 2 | 136 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Apr 9, 2014 | clinicaltrials |
| NCT02072317 | Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer | unknown | Phase 2 | 140 | Fudan UniversityOTHER | 1 | Feb 26, 2014 | clinicaltrials |
| NCT01584336 | Laparoscopy-assisted Total Gastrectomy for Clinical Stage I Gastric Cancer (KLASS-03)(KLASS-03) | unknown | Phase 2 | 168 | Soonchunhyang University HospitalOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT02038621 | The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer(GZH-001) | unknown | Phase 2 | 224 | The Second People's Hospital of SichuanOTHER | 0 | Jan 16, 2014 | clinicaltrials |
| NCT00553683 | Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer | unknown | Phase 1 / Phase 2 | 50 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT02024217 | Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric Carcinoma(NEWEAR) | unknown | Phase 2 | 40 | Fudan UniversityOTHER | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00005607 | Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus | unknown | Phase 2 | — | Robert H. Lurie Cancer CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005876 | Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery | unknown | Phase 2 | — | Astex Pharmaceuticals, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT01964027 | The Study of Irinotecan Plus Epirubicin as the Second-line Chemoregime for Advanced Gastric Cancer(SIEG) | unknown | Phase 2 | 40 | Anhui Medical UniversityOTHER | 1 | Oct 17, 2013 | clinicaltrials |
| NCT01963702 | A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC | unknown | Phase 2 | 120 | Fudan UniversityOTHER | 1 | Oct 16, 2013 | clinicaltrials |
| NCT01180166 | Combination of Nimotuzumab,Capecitabine and Radiotherapy for Inoperable or Recurrent Gastric Cancer | unknown | Phase 2 | 30 | Chinese Academy of Medical SciencesOTHER | 1 | Sep 19, 2013 | clinicaltrials |
| NCT00088816 | S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer | unknown | Phase 2 | 50 | Kyoto UniversityOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00134095 | S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | unknown | Phase 2 | 70 | Fukushima Medical University HospitalOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT01798251 | XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach | unknown | Phase 2 | 40 | Harbin Medical UniversityOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT01836991 | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer | unknown | Phase 2 | 200 | Zhejiang Cancer HospitalOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT01836120 | A Study of Raltitrexed Plus Docetaxel Versus Docetaxel as Second-line Chemotherapy in Subjects With Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Apr 19, 2013 | clinicaltrials |
| NCT01795768 | Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours(FGFR) | unknown | Phase 2 | 48 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01787539 | The Role of Postoperative Cycles in the Perioperative Chemotherapy for Gastric Cancer(STOPEROPCHEM) | unknown | Phase 2 / Phase 3 | 180 | Medical University of LublinOTHER | 1 | Feb 8, 2013 | clinicaltrials |
| NCT01747707 | Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer | unknown | Phase 2 | 40 | Chinese Academy of Medical SciencesOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01471132 | Sequential HIPEC of Oxaliplatin and Paclitaxel for Gastric Cancer Patients With Peritoneum Metastasis(SHOP-G01) | unknown | Phase 2 | 20 | Peking UniversityOTHER | 1 | Dec 7, 2012 | clinicaltrials |
| NCT01718626 | Study Comparing Sequential Therapy of S1+Docetaxel Followed by S1 to Concomitant S1+Docetaxel for Advanced Gastric Cancer | unknown | Phase 2 | 100 | Hebei Tumor HospitalOTHER | 1 | Nov 6, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01573468 | Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer(TESEGAST) | unknown | Phase 2 | 580 | Genta IncorporatedINDUSTRY | 3 | Jul 24, 2012 | clinicaltrials |
| NCT01642953 | Early Recovery After Gastric Cancer Surgery | unknown | Phase 2 | 109 | Ajou University School of MedicineOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT01641783 | Efficacy and Safety Study of ABI-007 Plus Capecitabine as First-line Chemotherapy for Advanced Gastric Cancer Patients | unknown | Phase 2 | 40 | Yanqiao ZhangOTHER | 0 | Jul 17, 2012 | clinicaltrials |
| NCT01552980 | Efficacy and Safety Study of a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma(mSOX) | unknown | Phase 2 | 30 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Mar 28, 2012 | clinicaltrials |
| NCT01558947 | Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer | unknown | Phase 2 | 2 | Zhejiang Cancer HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01095120 | Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer | unknown | Phase 2 | 27 | Genta IncorporatedINDUSTRY | 2 | Mar 15, 2012 | clinicaltrials |
| NCT01348009 | Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 63 | Genta IncorporatedINDUSTRY | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00821912 | TaxXel: Taxotere and Xeloda in Esophageal Cancer(TaxXel) | unknown | Phase 1 / Phase 2 | 93 | Karolinska University HospitalOTHER | 2 | Feb 28, 2012 | clinicaltrials |
| NCT01528059 | Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes | unknown | Phase 2 / Phase 3 | 110 | feng ZhengOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01426646 | S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer | unknown | Phase 2 | 218 | Kyungpook National University HospitalOTHER | 1 | Jan 5, 2012 | clinicaltrials |
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | unknown | Phase 1 / Phase 2 | 53 | Hanmi Pharmaceutical Company LimitedINDUSTRY | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00985556 | Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer | unknown | Phase 2 | 130 | Yonsei UniversityOTHER | 1 | Oct 20, 2011 | clinicaltrials |
| NCT00865982 | Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer(DCXAIOCHARITE) | unknown | Phase 2 | 50 | Charite University, Berlin, GermanyOTHER | 1 | Aug 5, 2011 | clinicaltrials |
| NCT01341756 | Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial | unknown | Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | May 9, 2011 | clinicaltrials |
| NCT01331928 | Sequential Chemotherapy With Xelox Follows by TX to Treat Gastric Cancer | unknown | Phase 2 | 51 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Apr 8, 2011 | clinicaltrials |
| NCT00178698 | Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors(FR-WB-TT/che) | unknown | Phase 2 | 36 | The University of Texas Health Science Center, HoustonOTHER | 1 | Mar 3, 2011 | clinicaltrials |
| NCT01305993 | Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer | unknown | Phase 2 | 26 | SBPharmaceutical IND, Co., LTDINDUSTRY | 1 | Mar 1, 2011 | clinicaltrials |
| NCT01160419 | Multicenter Study to Perioperative Chemotherapy for Resectable Adenocarcinoma in Gastric Cancer | unknown | Phase 2 | 49 | Ludwig-Maximilians - University of MunichOTHER | 1 | Oct 28, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Apr 22, 2015source: clinicaltrials